Study of SI-B036 for advanced gynecological and other solid tumors
This trial tests an investigational drug, SI-B036, in people with advanced gynecological cancers or other solid tumors that have spread. The goal is to see if the drug is safe and effective in shrinking tumors or slowing their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have advanced (locally advanced or metastatic) gynecological cancer or another type of solid tumor.
- You have at least one tumor that can be measured on imaging scans.
- You are well enough to carry out daily activities (ECOG score 0 or 1).
- You have recovered from side effects of previous treatments to a mild level.
- You can provide a tumor tissue sample (either stored or fresh).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SI-B036 for people whose head and neck cancer or other solid tumor has spread or cannot be removed surgically. The goal is to see if the drug can shrink tumors or slow their growth. The drug is given by infusion and works by targeting cancer cells.
This trial tests a new drug, BG-C0902, alone or with other treatments, for people with advanced solid tumors that have not responded to standard therapies. The goal is to see if it is safe and effective.
This trial studies an experimental drug called BL-M09D1. It is given to people with certain gynecologic cancers and other solid tumors that have advanced and not responded to standard treatment. The goal is to see if the drug can help shrink or control the cancer.
This trial tests an experimental drug called IBI3020 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective for these patients.
This trial tests a new drug called SI-B036 in people with advanced digestive tract or other solid tumors that have spread. It aims to see if the drug is safe and effective. You may qualify if you have a measurable tumor and are in relatively good health.
This trial tests a new drug called SI-B036 for people with advanced urinary tract cancers or other solid tumors that have spread or cannot be removed. The goal is to see if the drug can shrink or stabilize the cancer.
Hear when a new Gynecological Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.